Nitric oxide (NO) has potent antiproliferative properties. In previous work we have shown that NO inhibits growth, induces differentiation and modulates gene expression in acute nonlymphocytic leukemia (ANLL) cells. The goal of this work was to determine whether the rate of NO delivery affected its growth inhibition of ANLL cells. We also wanted to determine whether the NO inhibition of ANLL cell growth is associated with the induction of apoptosis. We treated HL-60 and U937 cells with three compounds that generate the same amount of NO but at different rates. MAMA-NO, PAPA-NO and DETA-NO have halflives of NO delivery of 2 and 30 min, and 20 h, respectively. The compound with the longest t . of NO delivery (DETA-NO) was the most potent inhibitor of leukemia cell and colony growth. Furthermore, the NO-induced growth inhibition was associated with apoptosis in a rate and concentration-dependent fashion.
Introduction
The role played by nitric oxide (NO) in biologic systems depends on the amount of NO produced as well as on the rate at which it is generated. NO plays a dual role depending on these factors. 1, 2 In vascular endothelial cells and neurons, the constitutive NO synthase (NOS1 and NOS3) continuously generate low levels of NO that play a crucial role in intercellular communication. 3, 4 The amount of NO they generate, and consequently its biologic effect, is dependent on intracellular levels of calcium and subsequent activation of NOS. 3, 4 By contrast, mononuclear phagocytes do not express NOS or generate NO constitutively. With immune stimulation, they produce the inducible NOS (NOS2) de novo. NOS2 is calcium/calmodulin-independent and generates large amounts of NO in a continuous fashion. 3, 4 This burst of NO production plays an important role in the host immune defense against micro-organisms and tumor cell growth. 1, 2 NO is potently cytotoxic to tumor cells in vitro. 5 It induces apoptosis in different cell types. 6, 7 We have previously shown that NO (delivered as a gas or by NO donating agents) inhibits growth, induces differentiation and modulates cytokine gene expression in the HL-60 human acute nonlymphocytic leukemia (ANLL) cell line. 8 We have also shown that NO inhibits the growth of ANLL cells freshly isolated from patients. 9 Furthermore, NO inhibits the growth of normal human bone marrow progenitor cells in a lineage-dependent fashion. 10 Even though the growth inhibitory effects of NO on leukemia cells are dose-dependent, the effect of the rate of NO delivery has not been determined. It is difficult to control or measure the rate of NO release from drugs such as sodium nitroprusside or S-nitroso N-acetyl penicillamine, drugs that are commonly used in in vitro experiments. The NO-nucleophile complexes known as the diazenium diolates or NONOates constitute a special class of NO-donating drugs. They generate two molecules of NO per molecule of carrier, but they differ by their rate of NO delivery with half-lives ranging from 2 min to several hours. 11 Thus, this class of NO-generating agents constitutes an ideal tool to study the effect of the rate of NO delivery on cell growth.
The aim of this work was to study the effect of the rate of NO delivery on the growth of human ANLL cells. We used three different diazenium diolates that generate NO at different rates and studied their effects on a myeloblastic (HL-60) and a monoblastic (U937) human ANLL cell line. We demonstrate that NO inhibits the growth of ANLL cells in a concentration-and rate-dependent manner. Furthermore, this growth inhibition is associated with the induction of apoptosis.
Methods

Cell lines and culture conditions
HL-60 and U937 cells were from ATCC (Rockville, MD, USA). For the suspension culture experiments, cells were cultured at a density of 150 000 cells/ml in RPMI-1640 with 10% fetal bovine serum at 37°C in a 5% CO 2 humidified atmosphere. Cells were cultured in a total volume of 1 ml with one well per variable. For the cultures in semi-solid media the cells were cultured under the same conditions at a density of 2000 cells/ml in methylcellulose media purchased from Stem Cells Technologies (Vancouver, BC, Canada). The medium contained 30% fetal bovine serum, 10% agar leukocyte-conditioned medium, 1% bovine serum albumin, 0.9% methylcellulose, 0.1 mM 2-mercaptoethanol, 2 mM glutamine, and 3 U/ml purified human urinary erythropoietin. Two separate wells were plated per variable. Leukemia colonies were scored using an inverted microscope 7 to 10 days after seeding. A leukemia colony (CFU-L) was defined as a cluster of 30 or more cells.
NO donors and treatments
We used three different diazenium diolates (Alexis, San Diego, CA, USA) as a source of NO. MAMA-NO, PAPA-NO and DETA-NO liberate two molecules of NO per carrier molecule. 11 At pH 7.4 and 37°C, their t . of NO release (ie the period of time during which they liberate half of their NO carrying capacity) is 2 min, 30 min, and 20 h, respectively.
11
One hundred mM NONOate solutions were made fresh in 0.01 N sodium hydroxide (NaOH) and added directly to the cell cultures at the indicated concentrations. Because of the high concentration of the NONOate stock solutions, the volume of NaOH did not affect the pH of the cell cultures. In the pretreatment experiments, cells were treated with the diazenium diolates for periods of time equal to their t . of NO release, centrifuged, washed in phosphate-buffered saline (PBS) and resuspended in either fresh liquid or semi-solid media. In order to ascertain that the observed results were due to NO and not to the NO-carrying moiety, we did negative control experiments using compounds consisting of the carrier moiety without NO. For MAMA-NO and PAPA-NO (the two compounds with short half-lives of NO generation), negative control compounds were generated by preparing 100 mM solutions of these compounds in PBS and incubating the solutions at 37°C for 7 days. This ensured that the compounds had liberated the vast majority of their NO and thus were 'spent'. For the DETA-NO negative controls, DETA was generously provided to us by Dr Larry K Keefer (National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, MD, USA).
Cell growth and apoptosis assays
The number of viable cells was determined by Trypan blue exclusion. Apoptosis was assayed by flow cytometry and by determining DNA laddering using gel electrophoresis. For the flow cytometry assay, we used the method of Nicoletti et al 12 with slight modification. In brief, cells were cultured in suspension media with the diazenium diolates as outlined above. The cells were then centrifuged, washed in PBS and resuspended in 1 ml lysis buffer consisting of 0.2% NP40 solution containing 5% bovine serum albumin in PBS. Ten microliters of a 5 mg/ml propidium iodide solution and 10 l of a 10 mg/ml RNAse A solution were then added. The fraction of cells with low DNA content (which is consistent with the apoptotic fraction) 12, 13 was determined using a Becton Dickinson flow cytometer. For the DNA laddering assay, cells were cultured in suspension media with the diazenium diolates as outlined above. They were then centrifuged, washed in PBS and DNA was isolated using the DNA blood kit from Qiagen (Chatsworth, CA, USA). Five micrograms of DNA were electrophoresced in a 1.2% agarose gel and stained with ethidium bromide. NP40, RNAse A, and propidium iodide were from Sigma (St Louis, MO, USA). Results are expressed as averages of multiple experiments with standard error or the mean (s.e.m.); s.e.m. was calculated as the standard deviation of different measurements divided by the square root of the number of measurements. Statistical analysis was done using the Student's t-test. Differences were considered statistically significant for P Ͻ 0.05.
Results
Effect of NO on cell proliferation
We started by determining the effect of the different NO donors on HL-60 cells, cells with a myeloid differentiation phenotype. MAMA-NO, PAPA-NO, or DETA-NO (25 to 1000 M) were added at the time of initiation of the cultures. After 3 days of culture, MAMA-NO (t . of NO release of 2 min) had essentially no effect on HL-60 cell growth (Figure 1a) . After 3 days in culture with PAPA-NO (t . of NO release of 30 min), HL-60 cell growth was inhibited by up to 74% (Figure 1a) . The 50% inhibitory dose (ID 50 ) of PAPA-NO was 100 M. DETA-NO (t . of NO release of 20 h) was the most potent growth inhibitor. It decreased HL-60 growth at 3 days by up to 100% (Figure 1a) , with an ID 50 of 50 M. In order to determine whether the differentiation phenotype of leukemia cells affects the response to NO, we studied the effect of the same NO donors on U937 (cells with a monoblastic leukemia phenotype). Unlike the HL-60 cells, U937 cell growth was inhibited by MAMA-NO, while PAPA-NO and DETA-NO inhibited to degrees comparable to that for HL-60 cells. MAMA-NO, PAPA-NO, and DETA-NO had ID 50 s of 500, 75 and 25 M, respectively (Figure 1b) .
Effect of NO on leukemia colony growth
Leukemia colony progenitors are self-renewing leukemia cells. When cultured in semi-solid media, these cells develop into colonies; the number of colonies reflects the number of leukemia colony-forming cells (CFU-L) in the cell population. In order to determine the effect of the rate of NO release on HL-60 CFU-L, cells were pretreated with MAMA-NO, PAPA-NO, or DETA-NO for periods of time equal to their t . of NO release (2 min, 30 min, and 20 h, respectively). Cells were then washed and cultured in methylcellulose semi-solid media as described in the Methods section. MAMA-NO or PAPA-NO (250 to 1000 M) pretreatment inhibited HL-60 CFU-L growth by up to 49 and 70% respectively (Figure 2 ). DETA-NO, which has the longest t . , inhibited HL-60 CFU-L growth by up to 95% (Figure 2 ). Similar results were noted when U937 cells were analyzed under the same conditions ( Figure 2 ).
Induction of apoptosis by NO
Because of previous reports showing apoptosis induction by NO, 6, 7 we sought to determine whether NO growth inhibition of ANLL cells is also associated with programmed cell death. We also wanted to determine whether the rate of NO delivery affects apoptosis induction in these cells. HL-60 cells were treated with each of the diazenium diolates for 3 days. The fraction of apoptotic cells was determined by flow cytometry as described in the Methods section. MAMA-NO modestly increased the fraction of apoptotic HL-60 cells (Figure 3a) . However, the MAMA-NO effects were not statistically significant. PAPA-NO increased the fraction of apoptotic HL-60 cells up to 53% (changes were statistically significant at PAPA-NO concentrations above 500 M) while DETA-NO increased the fraction of apoptotic cells up to 80% with statistically significant changes at concentrations greater than 100 M ( Figure  3a) . Thus, the rank order of effectiveness of the NONOates in inducing apoptosis and in inhibiting cell growth in liquid and semisolid media was comparable.
In order to determine whether apoptosis induction was dependent on the rate of NO release from the NO prodrugs, HL-60 cells were treated with each of the NO donors for periods of time equal to their t . of NO release. They were then washed and resuspended in fresh media for 24 h, and the fraction of apoptotic cells was determined by flow cytometry. Thus, in this experimental analysis, cells treated with the NO donors were exposed to the same cumulative amount of NO, but the NO was delivered at different rates. Under these circumstances, MAMA-NO did not significantly increase the number of apoptotic HL-60 cells, while PAPA-NO increased Effect of NO donors on HL-60 (a) and U937 (b) cell growth: HL-60 (a) or U937 (b) cells were cultured in suspension media for 3 days. Each NO donor was added at the time of culture at the indicated concentrations. Cells were counted after 3 days. MAMA-NO had minimal effects on cell growth while PAPA-NO and DETA-NO inhibited cell growth in a dose-dependent fashion. The NO donor with the longest t . of NO release (DETA-NO) was the most potent inhibitor. The plots reflect the means of two separate experiments with s.e.m. for each cell line.
Figure 2
Effect of NO donors on CFU-L growth: HL-60 (a) or U937 (b) cells were cultured in suspension media with MAMA-NO, PAPA-NO, or DETA-NO for periods of time equal to their t . of NO release (2 min, 30 min, and 20 h, respectively), and at the indicated concentrations. They were then washed in PBS and cultured in semi-solid methylcellulose media. CFU-L were scored at day 7-10. Pretreatment of the cells with the NO donors led to a dose-dependent decrease in the number of CFU-L. The NO donor with the longest t . of NO release was the most potent agent. The data are presented as the number of colonies (percent of control colony number). Controls had a mean of 190 and 62 colonies per well for HL-60 and U937 cell, respectively. The graphs represent the means with s.e.m. of seven and five experiments for HL-60 and U937 cells, respectively. Asterisks indicate statistically significant differences between treatments and controls.
the fraction of apoptotic cells up to 44% (Figure 3b) . However, the PAPA-NO effects were statistically significant only at a concentration of 1000 M. Pretreatment with DETA-NO increased the fraction of apoptotic cells by up to 82% with statistically significant changes for concentrations above 100 M (Figure 3b ). Apoptosis as determined by flow cytometry was confirmed by demonstrating DNA laddering on gel electrophoresis (Figure 4) . Similar results were obtained when U937 cells were treated under the same conditions ( Figure 5 ). These results were confirmed by DNA laddering experiments (data not shown). In order to ascertain that the observed effects were due to NO and not to the chemical carrier moiety, we repeated the experiments using equimolar concentrations of compounds consisting of the NO-carrying moiety Induction of apoptosis by NO donors in HL-60 cells: HL-60 cells were treated with MAMA-NO, PAPA-NO, or DETA-NO for a period of 24 h at the indicated concentrations. Cellular DNA was then isolated and electrophoresced in a 1.2% agarose gel. The NO donors induced apoptosis (as shown by DNA laddering) in a dose-dependent manner. The figure shows the results of one experiment that is representative of two performed.
without NO (MAMA, PAPA and DETA) as described in the Methods section. They did not inhibit cell growth or induce apoptosis (data not shown).
Discussion
In the present work, we demonstrate that NO inhibits growth and induces apoptosis in ANLL cells. Furthermore, by using three NO donors that generate equal amounts of NO but differ by their rate of NO generation, we demonstrate that the growth inhibitory effects of NO are dependent on the rate of NO generation. MAMA-NO, which generates NO very rapidly (t . of 2 min) had very minimal effects on the growth of HL-60 or U937 cells. PAPA-NO has a t . of NO generation of 30 min; it was more potent in its growth inhibitory effects. However, it had mainly a cytostatic effect since its growth inhibition was not paralleled by induction of apoptosis unless it was used at relatively high concentrations. DETA-NO which has a t . of NO release of 20 h was clearly the most potent inhibitor. Even though it inhibited cell growth at concentrations as low as 25 M, DETA-NO was mainly cytostatic until concentrations of 100 M were reached since it did not affect the number of apoptotic cells until this higher dose level was reached. Pretreatment of leukemia cells inhibited CFU-L growth even after withdrawal of the NO donor; this indicates the growth inhibitory effects of NO on leukemia progenitor cells are irreversible. It is important to note that in our experiments the NO donors were added only once. Thus, we expect that repeated additions would require lower concentrations of the NO donors for growth inhibition. In spite of their different phenotypes, there was no clear differences in susceptibility to the NO effects between the two cell lines. For induction of growth inhibition and apoptosis, the rate at which a cell is exposed to NO appears to be at least as important as the amount of NO to which it is exposed. Even at a concentration as high as 1000 M, MAMA-NO was far less effective than lower concentrations of either PAPA-NO or DETA-NO. Similar results were reported by Mooradian et al 14 when vascular smooth muscle cells were treated with drugs that generate NO at different rates.
It is not clear why a prolonged exposure to NO is required for growth inhibition. NO has a very short t . in solution.
1,2 It is therefore quite possible that a drug that liberates NO very rapidly (such as MAMA-NO) would lose its effectiveness before affecting a significant number of cells. Leukemia cells do not divide synchronously. Actively dividing cells may be more susceptible to NO, and therefore a slow release of NO would affect a larger number of dividing cells. On the other hand, since NO inhibited CFU-L growth even after it was removed from the culture system, it may permanently affect a cellular target that leads to death once the cell divides. The in vitro situation created by the slow release of NO by agents such as DETA-NO reproduces to a certain extent the situation observed when activated macrophages are immunologically stimulated to produce NO and consequently inhibit cell growth. 5 NO has multiple intracellular targets that could potentially affect cell growth. [15] [16] [17] These include protein tyrosine nitration by generating peroxynitrite, nitrosylation of thiol residues, ADP-ribosylation, ribonucleotide reductase inhibition, and the induction of DNA strand breaks. In the current work, we show that NO induces apoptosis in HL-60 and U937 cells in a dose-dependent fashion, with the rank order of effectiveness for apoptosis and for inhibiting cell growth in liquid and semisolid media being comparable. Importantly, the induction of apoptosis was also dependent on the rate of NO delivery. NO has been shown to induce apoptosis in different cellular systems. 6, 7, 18 In a recent paper, Messmer and Brü ne 19 showed that NO induces apoptosis in RAW 264.7 cells by up-regulating the tumor suppressor gene p53, while it induced apoptosis in U937 cells by a p53-independent mechanism. Kuo et al 20 have suggested that NO induces apoptosis in HL-60 cells through the activation of poly(ADP-ribose) polymerase, while Lin et al 21 demonstrated that peroxynitrite induces apoptosis in these cells. Genaro et al 22 noted that at very low concentrations, NO protects B-lymphocytes from apoptosis by maintaining bcl-2 levels. More recently, Saavedra et al 23 demonstrated that a liver-selective NO donor that generates low levels of NO when activated by a cellular enzyme protects hepatocytes from tumor necrosis factor-␣-induced apoptosis. Thus, NO could be playing a dual role in apoptosis -at very low levels it inhibits apoptosis, while when generated at high levels and for prolonged periods of time, it induces apoptosis.
We conclude that NO is a potent inhibitor of ANLL cell growth by a mechanism that could involve apoptosis. However, this growth inhibition and apoptosis induction requires a prolonged exposure of the cells to NO. Thus, any therapeutic use of NO for the treatment of cancer or leukemia would likely require the use of a long-acting agent or repeated treatments with a shorter-acting agent.
